Beijing Tiantan Biological Products Co., Ltd. (600161.SS) SHH

19.04

+0.01(+0.05%)

Updated at October 20 11:25AM

Currency In CNY

Valuation

Market Cap40.72B
Enterprise Value38.07B
P/E Ratio25.91
PEG Ratio9.2
Price/Sales Ratio5.98
Price/Book Ratio3.26
Enterprise/Revenue5.7
Enterprise/EBITDA13.58

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.23
Operating Margin0.38

Management Effectiveness

Return On Assets0.09
Return On Equity0.13

Income Statement

Revenue6.03B
Revenue/Share3.19
Gross Profit3.29B
EBITDA2.78B
Net Income1.55B
Diluted EPS0.78

Balance Sheet

Total Cash1.9B
Total Cash/Share1.23
Total Debt94.7M
Total Debt/Equity0.01
Current Ratio6.39
Book Value Per Share7.58

Price History

52-Week Change-12.88
52-Week High23.61
52-Week Low18.86
Moving Average 50 Days19.7
Moving Average 200 Days19.93

Statistics

Average Volume18.05M
Shares Outstanding1.98B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield1.31
Payout Ratio0
Last Split Factor6:5
Last Split DateJune 20, 2024